KR19990077165A - 신규한 치환 이미다졸 화합물 - Google Patents

신규한 치환 이미다졸 화합물 Download PDF

Info

Publication number: KR19990077165A
Authority: KR; South Korea
Prior art keywords: alkyl; formula; compound; imidazole; disease
Prior art date: 1996-01-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

KR1019980705303A

Other languages

English (en)

Korean (ko)

Inventor

제리 엘. 아담스

제프리 시. 보엠

Original Assignee

스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스

스미스클라인 비참 코포레이션

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-11

Filing date

1997-01-10

Publication date

1999-10-25

1997-01-10 Application filed by 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스, 스미스클라인 비참 코포레이션 filed Critical 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스

1999-10-25 Publication of KR19990077165A publication Critical patent/KR19990077165A/ko

Status Ceased legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Neurology (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)

KR1019980705303A 1996-01-11 1997-01-10 신규한 치환 이미다졸 화합물 Ceased KR19990077165A (ko)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US990996P	1996-01-11	1996-01-11
US60/009,909		1996-01-11

Publications (1)

Publication Number	Publication Date
KR19990077165A true KR19990077165A (ko)	1999-10-25

Family

ID=21740430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1019980705303A Ceased KR19990077165A (ko)	1996-01-11	1997-01-10	신규한 치환 이미다졸 화합물

Country Status (26)

Country	Link
US (3)	US6214844B1 (2)
EP (1)	EP0935465B1 (2)
JP (2)	JP2000503303A (2)
KR (1)	KR19990077165A (2)
CN (1)	CN1213307A (2)
AR (1)	AR006307A1 (2)
AT (1)	ATE264105T1 (2)
AU (1)	AU726084C (2)
BR (1)	BR9706934A (2)
DE (1)	DE69728685T2 (2)
DK (1)	DK0935465T3 (2)
EA (1)	EA001430B1 (2)
ES (1)	ES2219750T3 (2)
HU (1)	HUP9900645A3 (2)
IL (1)	IL125282A (2)
MX (1)	MX9805634A (2)
NO (1)	NO316625B1 (2)
NZ (1)	NZ327052A (2)
OA (1)	OA11514A (2)
PL (1)	PL187616B1 (2)
PT (1)	PT935465E (2)
SK (2)	SK92798A3 (2)
TR (1)	TR199801360T2 (2)
TW (1)	TW523512B (2)
WO (1)	WO1997025046A1 (2)
ZA (1)	ZA97175B (2)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5916891A (en)	1992-01-13	1999-06-29	Smithkline Beecham Corporation	Pyrimidinyl imidazoles
ZA9610687B (en) *	1995-12-22	1997-09-29	Smithkline Beecham Corp	Novel synthesis.
PL187516B1 (pl) *	1996-01-11	2004-07-30	Smithkline Beecham Corp	Nowe podstawione pochodne imidazolu, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca te związki
US6046208A (en) *	1996-01-11	2000-04-04	Smithkline Beecham Corporation	Substituted imidazole compounds
ZA97175B (en)	1996-01-11	1997-11-04	Smithkline Beecham Corp	Novel substituted imidazole compounds.
AP9700912A0 (en)	1996-01-11	1997-01-31	Smithkline Beecham Corp	Novel cycloalkyl substituted imidazoles
JP2000507558A (ja) *	1996-03-25	2000-06-20	スミスクライン・ビーチャム・コーポレイション	Ｃｎｓ損傷についての新規な治療
WO1998007425A1 (en)	1996-08-21	1998-02-26	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
US6147080A (en) *	1996-12-18	2000-11-14	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US6608060B1 (en)	1996-12-18	2003-08-19	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US5945418A (en) *	1996-12-18	1999-08-31	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US5929076A (en) *	1997-01-10	1999-07-27	Smithkline Beecham Corporation	Cycloalkyl substituted imidazoles
US6514977B1 (en)	1997-05-22	2003-02-04	G.D. Searle & Company	Substituted pyrazoles as p38 kinase inhibitors
AU7726898A (en)	1997-05-22	1998-12-11	G.D. Searle & Co.	Pyrazole derivatives as p38 kinase inhibitors
US6979686B1 (en)	2001-12-07	2005-12-27	Pharmacia Corporation	Substituted pyrazoles as p38 kinase inhibitors
CA2294057A1 (en)	1997-06-13	1998-12-17	Smithkline Beecham Corporation	Novel pyrazole and pyrazoline substituted compounds
AU8154998A (en)	1997-06-19	1999-01-04	Smithkline Beecham Corporation	Novel aryloxy substituted pyrimidine imidazole compounds
US7301021B2 (en)	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
TW517055B (en)	1997-07-02	2003-01-11	Smithkline Beecham Corp	Novel substituted imidazole compounds
WO1999001452A1 (en)	1997-07-02	1999-01-14	Smithkline Beecham Corporation	Novel cycloalkyl substituted imidazoles
US6562832B1 (en)	1997-07-02	2003-05-13	Smithkline Beecham Corporation	Substituted imidazole compounds
US6489325B1 (en)	1998-07-01	2002-12-03	Smithkline Beecham Corporation	Substituted imidazole compounds
WO1999017776A1 (en)	1997-10-08	1999-04-15	Smithkline Beecham Corporation	Novel cycloalkenyl substituted compounds
WO1999032121A1 (en)	1997-12-19	1999-07-01	Smithkline Beecham Corporation	Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
CN1548436A (zh)	1998-05-22	2004-11-24	ʷ��˿��ȳ�ķ��޹�˾	新的2-烷基取代咪唑化合物
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
JP2003525201A (ja)	1998-08-20	2003-08-26	スミスクライン・ビーチャム・コーポレイション	新規な置換トリアゾール化合物
WO2000025791A1 (en)	1998-11-04	2000-05-11	Smithkline Beecham Corporation	Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
US6239279B1 (en)	1998-12-16	2001-05-29	Smithkline Beecham Corporation	Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
US7122666B2 (en) *	1999-07-21	2006-10-17	Sankyo Company, Limited	Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
EP1233951B1 (en)	1999-11-23	2005-06-01	SmithKline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
AU1781601A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
US6759410B1 (en) *	1999-11-23	2004-07-06	Smithline Beecham Corporation	3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
ATE305787T1 (de)	1999-11-23	2005-10-15	Smithkline Beecham Corp	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
ATE283048T1 (de) *	1999-12-08	2004-12-15	Pharmacia Corp	Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
US7235551B2 (en) *	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
WO2002005848A2 (en) *	2000-07-13	2002-01-24	Pharmacia Corporation	Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
PE20020146A1 (es) *	2000-07-13	2002-03-31	Upjohn Co	Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
HUP0302068A3 (en)	2000-07-20	2005-05-30	Lauras As	Use of cox-2 inhibitors for treating or preventing immunodeficiency and pharmaceutical compositions containing them
JP2004530648A (ja) *	2000-10-19	2004-10-07	スミスクライン・ビーチャム・コーポレイション	炎症により促進される咳の治療のためのｐ３８阻害剤の使用
ATE521353T1 (de) *	2000-10-23	2011-09-15	Glaxosmithkline Llc	Neues trisubstitutiertes 8h-pyridoä2,3- düpyrimidin-7-onderivat zur behandlung von durch csbp/p38kinase vermittelten krankheiten
US7115565B2 (en) *	2001-01-18	2006-10-03	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
CA2440211A1 (en)	2001-03-09	2002-09-19	Pfizer Products Inc.	Benzimidazole anti-inflammatory compounds
EE200300437A (et) *	2001-03-09	2004-02-16	Pfizer Products Inc.	Triasolopüridiinid kui põletikuvastased ained
MY137736A (en)	2001-04-03	2009-03-31	Pharmacia Corp	Reconstitutable parenteral composition
ES2247271T3 (es)	2001-04-04	2006-03-01	Pfizer Products Inc.	Nuevos benzotriazoles como compuestos antiinflamatorios.
UA80682C2 (en) *	2001-08-06	2007-10-25	Pharmacia Corp	Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
AR039241A1 (es) *	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
US20030225089A1 (en) *	2002-04-10	2003-12-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
DE60310730T2 (de)	2002-07-09	2007-05-16	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
EP1539121A4 (en) *	2002-08-29	2008-08-13	Scios Inc	METHOD OF REQUESTING OSTEOGENESIS
US7005523B2 (en) *	2002-08-30	2006-02-28	Pfizer Inc.	Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
US7012143B2 (en)	2002-08-30	2006-03-14	Dombroski Mark A	Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US6949652B2 (en) *	2002-08-30	2005-09-27	Pfizer, Inc.	Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine
PA8579601A1 (es) *	2002-08-30	2004-05-07	Pfizer Prod Inc	Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
US20040092547A1 (en) *	2002-08-30	2004-05-13	Pfizer Inc	Alkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US7037923B2 (en) *	2002-08-30	2006-05-02	Pfizer, Inc.	Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines
JP2006503025A (ja) *	2002-09-05	2006-01-26	サイオスインク．	ｐ３８ＭＡＰキナーゼの抑制による疼痛治療
US20080039461A1 (en) *	2002-09-05	2008-02-14	Protter Andrew A	Treatment of pain by inhibition of p38 map kinase
UA80295C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Pyrazolopyridines and using the same
UA80296C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Imidazolopyridines and methods of making and using the same
CL2004000234A1 (es) *	2003-02-12	2005-04-15	Biogen Idec Inc	Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
CA2515190A1 (en) *	2003-02-14	2004-08-26	Pfizer Products Inc.	Triazolo-pyridines as anti-inflammatory compounds
CL2004000366A1 (es) *	2003-02-26	2005-01-07	Pharmacia Corp Sa Organizada B	USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
US7105467B2 (en) *	2003-07-08	2006-09-12	Pharmacore, Inc.	Nickel catalyzed cross-coupling reactions between organomagnesium compounds and anisole derivatives
US7244441B2 (en)	2003-09-25	2007-07-17	Scios, Inc.	Stents and intra-luminal prostheses containing map kinase inhibitors
US7454007B2 (en) *	2004-03-26	2008-11-18	Samsung Electronics Co., Ltd.	Telecommunication switch using generic API to support multiple protocol-specific signal control functions
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EP1676574A3 (en)	2004-12-30	2006-07-26	Johnson & Johnson Vision Care, Inc.	Methods for promoting survival of transplanted tissues and cells
UY29440A1 (es)	2005-03-25	2006-10-02	Glaxo Group Ltd	Nuevos compuestos
EP1865959A2 (en) *	2005-03-25	2007-12-19	Glaxo Group Limited	Process for preparing pyridoý2,3-d¨pyrimidin-7-one and 3,4-dihydropyrimidoý4,5-d¨pyrimidin-2(1h)-one derivatives
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US8523889B2 (en) *	2007-07-27	2013-09-03	Ethicon Endo-Surgery, Inc.	Ultrasonic end effectors with increased active length
EP2799537B1 (en)	2011-12-28	2021-09-22	Kyoto Prefectural Public University Corporation	Normalization of culture of corneal endothelial cells
WO2015072580A1 (ja)	2013-11-14	2015-05-21	学校法人同志社	細胞増殖促進または細胞障害抑制による角膜内皮治療薬
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071147A1 (en)	2017-10-05	2019-04-11	Fulcrum Therapeutics, Inc.	INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD
WO2022195579A1 (en)	2021-03-15	2022-09-22	Saul Yedgar	Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3707475A (en) *	1970-11-16	1972-12-26	Pfizer	Antiinflammatory imidazoles
US3929807A (en) *	1971-05-10	1975-12-30	Ciba Geigy Corp	2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
US3940486A (en) *	1971-05-10	1976-02-24	Ciba-Geigy Corporation	Imidazole derivatives in the treatment of pain
US4058614A (en) *	1973-12-04	1977-11-15	Merck & Co., Inc.	Substituted imidazole compounds and therapeutic compositions therewith
US4199592A (en) *	1978-08-29	1980-04-22	E. I. Du Pont De Nemours And Company	Antiinflammatory 4,5-diaryl-2-nitroimidazoles
GR75287B (2) *	1980-07-25	1984-07-13	Ciba Geigy Ag
US4503065A (en) *	1982-08-03	1985-03-05	E. I. Du Pont De Nemours And Company	Antiinflammatory 4,5-diaryl 1-2-halo imidazoles
US4565875A (en) *	1984-06-27	1986-01-21	Fmc Corporation	Imidazole plant growth regulators
US4686231A (en) *	1985-12-12	1987-08-11	Smithkline Beckman Corporation	Inhibition of 5-lipoxygenase products
IL83467A0 (en) *	1986-08-15	1988-01-31	Fujisawa Pharmaceutical Co	Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
JPH06504779A (ja) *	1990-12-13	1994-06-02	スミスクライン・ビーチャム・コーポレイション	新規ｃｓａｉｄｓ
IE914327A1 (en) *	1990-12-13	1992-06-17	Smithkline Beecham Corp	Novel csaids
US5593992A (en)	1993-07-16	1997-01-14	Smithkline Beecham Corporation	Compounds
US5670527A (en) *	1993-07-16	1997-09-23	Smithkline Beecham Corporation	Pyridyl imidazole compounds and compositions
IL110296A (en) *	1993-07-16	1999-12-31	Smithkline Beecham Corp	Imidazole compounds process for their preparation and pharmaceutical compositions containing them
US5593991A (en) *	1993-07-16	1997-01-14	Adams; Jerry L.	Imidazole compounds, use and process of making
KR100330553B1 (ko) *	1993-10-01	2002-11-27	노파르티스 아게	약물학적활성피리딘유도체및그의제조방법
US5543520A (en) *	1993-10-01	1996-08-06	Ciba-Geigy Corporation	Pyrimidine derivatives
WO1995009851A1 (en) *	1993-10-01	1995-04-13	Ciba-Geigy Ag	Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof
JPH08503971A (ja) *	1993-10-01	1996-04-30	チバ−ガイギーアクチェンゲゼルシャフト	ピリミジンアミン誘導体及びその調製のための方法
FI972970A7 (fi) *	1995-01-12	1997-09-11	Smithkline Beecham Corp	Uusia yhdisteitä
IL118544A (en) *	1995-06-07	2001-08-08	Smithkline Beecham Corp	History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
ZA97175B (en) *	1996-01-11	1997-11-04	Smithkline Beecham Corp	Novel substituted imidazole compounds.

1997
- 1997-01-09 ZA ZA9700175A patent/ZA97175B/xx unknown
- 1997-01-10 SK SK927-98A patent/SK92798A3/sk unknown
- 1997-01-10 IL IL12528297A patent/IL125282A/xx not_active IP Right Cessation
- 1997-01-10 AU AU15782/97A patent/AU726084C/en not_active Ceased
- 1997-01-10 NZ NZ327052A patent/NZ327052A/xx unknown
- 1997-01-10 WO PCT/US1997/000529 patent/WO1997025046A1/en not_active Ceased
- 1997-01-10 DK DK97902013T patent/DK0935465T3/da active
- 1997-01-10 AT AT97902013T patent/ATE264105T1/de not_active IP Right Cessation
- 1997-01-10 DE DE69728685T patent/DE69728685T2/de not_active Expired - Fee Related
- 1997-01-10 JP JP9525459A patent/JP2000503303A/ja not_active Ceased
- 1997-01-10 ES ES97902013T patent/ES2219750T3/es not_active Expired - Lifetime
- 1997-01-10 HU HU9900645A patent/HUP9900645A3/hu not_active Application Discontinuation
- 1997-01-10 EA EA199800633A patent/EA001430B1/ru not_active IP Right Cessation
- 1997-01-10 PT PT97902013T patent/PT935465E/pt unknown
- 1997-01-10 CN CN97193002A patent/CN1213307A/zh active Pending
- 1997-01-10 EP EP97902013A patent/EP0935465B1/en not_active Expired - Lifetime
- 1997-01-10 AR ARP970100104A patent/AR006307A1/es not_active Application Discontinuation
- 1997-01-10 PL PL97327934A patent/PL187616B1/pl not_active IP Right Cessation
- 1997-01-10 US US09/101,550 patent/US6214844B1/en not_active Expired - Fee Related
- 1997-01-10 SK SK928-98A patent/SK92898A3/sk unknown
- 1997-01-10 BR BR9706934-5A patent/BR9706934A/pt not_active Application Discontinuation
- 1997-01-10 KR KR1019980705303A patent/KR19990077165A/ko not_active Ceased
- 1997-01-10 TR TR1998/01360T patent/TR199801360T2/xx unknown
- 1997-01-10 US US08/781,466 patent/US5716955A/en not_active Expired - Fee Related
- 1997-08-22 TW TW086112052A patent/TW523512B/zh not_active IP Right Cessation
- 1997-11-21 US US08/976,522 patent/US5811549A/en not_active Expired - Fee Related
1998
- 1998-07-10 OA OA9800113A patent/OA11514A/en unknown
- 1998-07-10 NO NO19983181A patent/NO316625B1/no not_active IP Right Cessation
- 1998-07-10 MX MX9805634A patent/MX9805634A/es not_active IP Right Cessation
2004
- 2004-01-08 JP JP2004003158A patent/JP2004107358A/ja active Pending

Also Published As

Publication number	Publication date
NO316625B1 (no)	2004-03-15
ATE264105T1 (de)	2004-04-15
HK1022624A1 (en)	2000-08-18
AU1578297A (en)	1997-08-01
MX9805634A (es)	1998-11-30
IL125282A0 (en)	1999-03-12
OA11514A (en)	2004-02-04
TW523512B (en)	2003-03-11
IL125282A (en)	2003-06-24
JP2004107358A (ja)	2004-04-08
TR199801360T2 (xx)	1998-10-21
US5811549A (en)	1998-09-22
EP0935465A1 (en)	1999-08-18
CN1213307A (zh)	1999-04-07
ZA97175B (en)	1997-11-04
JP2000503303A (ja)	2000-03-21
WO1997025046A1 (en)	1997-07-17
SK92798A3 (en)	1999-05-07
US5716955A (en)	1998-02-10
BR9706934A (pt)	2000-10-24
ES2219750T3 (es)	2004-12-01
HUP9900645A3 (en)	2000-03-28
PT935465E (pt)	2004-08-31
NZ327052A (en)	2000-01-28
US6214844B1 (en)	2001-04-10
AR006307A1 (es)	1999-08-25
HUP9900645A2 (hu)	1999-06-28
EA199800633A1 (ru)	1999-02-25
SK92898A3 (en)	1999-05-07
EA001430B1 (ru)	2001-02-26
PL327934A1 (en)	1999-01-04
AU726084B2 (en)	2000-11-02
DK0935465T3 (da)	2004-08-09
NO983181L (no)	1998-09-10
DE69728685D1 (de)	2004-05-19
PL187616B1 (pl)	2004-08-31
DE69728685T2 (de)	2005-04-14
EP0935465B1 (en)	2004-04-14
EP0935465A4 (2)	1999-08-18
AU726084C (en)	2001-08-30

Legal Events

Date	Code	Title	Description
1998-07-10	PA0105	International application	Patent event date: 19980710 Patent event code: PA01051R01D Comment text: International Patent Application
1999-10-25	PG1501	Laying open of application
2002-01-09	A201	Request for examination
2002-01-09	PA0201	Request for examination	Patent event code: PA02012R01D Patent event date: 20020109 Comment text: Request for Examination of Application
2004-02-27	E902	Notification of reason for refusal
2004-02-27	PE0902	Notice of grounds for rejection	Comment text: Notification of reason for refusal Patent event date: 20040227 Patent event code: PE09021S01D
2004-05-04	E601	Decision to refuse application
2004-05-04	PE0601	Decision on rejection of patent	Patent event date: 20040504 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20040227 Comment text: Notification of reason for refusal Patent event code: PE06011S01I

Publication	Publication Date	Title
US5716955A (en)	1998-02-10	Substituted imidazole compounds
RU2196139C2 (ru)	2003-01-10	1,4,5-тризамещенные производные имидазола, способы их получения и фармацевтическая композиция на их основе
EP0831830B1 (en)	2003-03-05	Imidazole compounds
EP0889726B1 (en)	2004-09-15	Novel cycloalkyl substituted imidazoles
US5739143A (en)	1998-04-14	Imidazole compounds and compositions
US5977103A (en)	1999-11-02	Substituted imidazole compounds
US5929076A (en)	1999-07-27	Cycloalkyl substituted imidazoles
HUP0102677A2 (hu)	2002-04-29	Triszubsztituált imidazolszármazékok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
AU763507B2 (en)	2003-07-24	Novel substituted imidazole compounds
KR19990077166A (ko)	1999-10-25	신규한 시클로알킬 치환 이미다졸
BG63362B1 (bg)	2001-11-30	Нови заместени имидазоли
HK1022624B (en)	2004-12-10	Novel substituted imidazole compounds
CZ219698A3 (cs)	2000-02-16	Nová substituovaná imidazolová sloučenina, způsob její přípravy, farmaceutický prostředek s jejím obsahem a způsob léčení
HK1057540A (en)	2004-04-08	Pyridyl and pyrimidinyl imines as intermediates for imidazole derivatives